CD8A and neoplasm: Furthermore, an iron oxide nanoparticle prodrug (FGR) with pH-sensitive properties releases the TLR7/8 agonist R848 under acidic TME conditions, promoting dendritic cell maturation and ICD while synergizing photothermal and chemodynamic effects to increase CD8+ T cell infiltration and suppress tumor growth and metastasis [39].